The original rationale for proton therapy was its highly conformal depth‐dose distributions
compared to photons, which allow greater sparing of normal tissues and escalation of tumor …

The treatment of cancer with proton radiation therapy was first suggested in 1946 followed
by the first treatments in the 1950s. As of 2020, almost 200 000 patients have been treated …

Lung cancer treatment is constantly evolving due to technological advances in the delivery
of radiation therapy. Adaptive radiation therapy (ART) allows for modification of a treatment …

Dose uncertainty induced by respiratory motion remains a major concern for treating
thoracic and abdominal lesions using particle beams. This Task Group report reviews the …

Charged particle therapy is the most advanced radiotherapy method in oncology. The
favorable depth-dose distribution and the biological properties of charged particles have …

Simple Summary Treatment of locally advanced non-small cell lung cancer (LA-NSCLC) is a
fine balance between toxicity and cure. Modern proton therapy might offer a more gentle …

Purpose To quantify tumor anatomic change of non-small cell lung cancer (NSCLC) patients
given passive-scattering proton therapy (PSPT) and intensity-modulated radiation therapy …

Purpose There are very little data available comparing outcomes of intensity-modulated
proton therapy (IMPT) to intensity-modulated radiation therapy (IMRT) in patients with locally …

Radiation therapy is an essential component of treatment for locally advanced non-small cell
lung cancer (NSCLC) but can be technically challenging because of the proximity of lung …

Definitive treatment of locally advanced non–small-cell lung cancer with radiation is
challenging. During the course of treatment, anatomical changes such as tumor regression …